Preventing Immune Problems When Starting HIV Treatment
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests whether a steroid medication can prevent a serious immune reaction (called IRIS) that sometimes happens when people with advanced HIV start antiretroviral therapy. The reaction occurs when the immune system restarts and overreacts to existing infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have confirmed HIV infection with a very low CD4 count (below 100 cells/μL—a measure of immune strength)
- You have an HIV-related opportunistic infection, such as a fungal or mycobacterial infection, PJP pneumonia, cryptococcal meningitis, CMV retinitis, or PML
- You are ready to start antiretroviral therapy (HIV medications) for the first time or as part of a treatment plan
- You weigh at least 40 kg (about 88 pounds)
- You do not have tuberculosis, Kaposi sarcoma, severe liver or kidney disease, or heart rhythm problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests whether two drugs work together to reduce hidden HIV in your body while you're on stable HIV treatment. The goal is to understand how safe the combination is and whether it helps clear dormant HIV cells.
This trial tests if adding steroids and stronger antibiotics can help people with HIV who are very sick from an infection. The goal is to find better treatment for those not getting better with standard care.
This trial tests if two drugs, baricitinib and sirolimus, can help control HIV after stopping standard antiretroviral therapy (ART). It aims to see if these immune treatments allow patients to maintain viral suppression without daily pills.
This study tests whether giving a small protein called IL-15 can help your immune system keep HIV under control after pausing your daily HIV medications. You will stop your meds for a short time under careful monitoring, and the hope is that your body might learn to fight HIV without daily pills.
This study looks at people with HIV who either have not started HIV medicines yet or who recently started/changed them and may develop immune rebound (IRIS). It uses blood tests and optional PET/CT scans and lymph node biopsies to understand what’s happening in the body and to guide care.
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.